Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease

Archives of Neurology

Volumn 60, Issue 6, 2003, Pages 813-816

  Geschwind, Michael D ^a,b   Martindale, Jennifer ^a   Miller, Deborah ^a   DeArmond, Stephen J ^a   Uyehara Lock, Jane ^a   Gaskin, David ^a   Kramer, JoeI H ^a   Barbaro, Nicholas M ^b   Miller, Bruce L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN 14 3 3;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LUMBAR PUNCTURE; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; SENSITIVITY ANALYSIS;

14-3-3 PROTEINS; ADULT; AGED; BIOLOGICAL MARKERS; CREUTZFELDT-JAKOB SYNDROME; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOBLOTTING; LABORATORY TECHNIQUES AND PROCEDURES; MALE; MIDDLE AGED; REFERENCE STANDARDS; TYROSINE 3-MONOOXYGENASE; UNITED STATES;

EID: 0037709838     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.60.6.813     Document Type: Article

References (17)

1. Satoh JI, Kurohara K, Yukitake M, Kuroda Y. The 14-3-3 protein detectable in the cerebrospinal fluid of patients with prion-unrelated neurological diseases is expressed constitutively in neurons and glial cells in culture. Eur Neurol. 1999;41:216-225.
2. Beaudry P, Cohen P, Brandel JP, et al. 14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrosinal fluid of patients with Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord. 1999;10:40-46.
3. Hsich G, Kenney K, Gibbs CH, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med. 1996;335:924-930.
4. Poser S, Mollenhauer B, Kraubeta A, et al. How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. Brain. 1999;122:2345-2351.
5. World Health Organization. Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: report of a WHO consultation. In: Emerging and Other Communicable Diseases, Surveillance and Control. Geneva, Switzerland: World Health Organization; 1998:1-26.
6. Burkhard P, Sanchez J-C, Landis T, Hochstrasser D. CSF detection of the 14-3-3 protein in unselected patients with dementia. Neurology. 2001;56:1528-1533.
7. Chapman T, McKeel DW Jr, Morris JC. Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease. Neurology. 2000;55:1396-1397.
8. Saiz A, Graus F, Dalmau J, Pifarre A, Marin C, Tolosa E. Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders. Ann Neurol. 1999;46:774-777.
9. Kenney KL, Hsich G, Brechtel C, Gibbs CJ. The cerebrospinal fluid 14-3-3 assay's diagnostic utility among clinically suspected CJD patients: the NIH experience. Paper presented at: American Academy of Neurology Annual Meeting; April 17, 2002; Denver, Colo.
10. Zerr I, Bodemer M, Gefeller O, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol. 1998;43:32-40.
11. Kretzschmar HA, Ironside JW, DeArmond SJ, Tateishi J. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol. 1996;53:913-920.
12. Muramoto T, Kitamoto T, Tateishi J, Goto I. The sequential development of abnormal prion protein accumulation in mice with Creutzfeldt-Jakob disease. Am J Pathol. 1992;140:1411-1420.
13. Zerr I, Pocchiari M, Collins S, et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology. 2000;55:811-815.
14. Lemstra AW, van Meegan MT, Vreyling JP, et al. 14-3-3 testing in diagnosing Creutzfeldt-Jakob disease. Neurology. 2000;55:514-516.
15. Will RG, Zeidler M, Stewart GE, et al. Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol. 2000;47:575-582.
16. Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature, 2001;411:810-813.
17. Safar JG, Scott M, Monaghan J, et al. Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nat Biotechnol. 2002;20:1147-1150.